Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Julphar
Boehringer Ingelheim
Cipla
AstraZeneca
Cantor Fitzgerald
Teva
Baxter
Medtronic
Express Scripts

Generated: August 23, 2017

DrugPatentWatch Database Preview

Ibuprofen; oxycodone hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ibuprofen; oxycodone hydrochloride and what is the scope of ibuprofen; oxycodone hydrochloride patent protection?

Ibuprofen; oxycodone hydrochloride
is the generic ingredient in two branded drugs marketed by Barr Labs Inc, Actavis Elizabeth, Forest Labs, and Watson Labs, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are sixty-four drug master file entries for ibuprofen; oxycodone hydrochloride. Two suppliers are listed for this compound.

Summary for Generic Name: ibuprofen; oxycodone hydrochloride

Tradenames:2
Patents:0
Applicants:4
NDAs:4
Drug Master File Entries: see list64
Suppliers / Packagers: see list2
Clinical Trials: see list2,994
Drug Prices:see low prices
DailyMed Link:ibuprofen; oxycodone hydrochloride at DailyMed

Pharmacology for Ingredient: ibuprofen; oxycodone hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth
OXYCODONE HYDROCHLORIDE AND IBUPROFEN
ibuprofen; oxycodone hydrochloride
TABLET;ORAL078769-001Jan 4, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Forest Labs
COMBUNOX
ibuprofen; oxycodone hydrochloride
TABLET;ORAL021378-001Nov 26, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
Barr Labs Inc
OXYCODONE HYDROCHLORIDE AND IBUPROFEN
ibuprofen; oxycodone hydrochloride
TABLET;ORAL078316-001Nov 29, 2007ABRXNoYes► Subscribe► Subscribe► Subscribe
Watson Labs
OXYCODONE HYDROCHLORIDE AND IBUPROFEN
ibuprofen; oxycodone hydrochloride
TABLET;ORAL078394-001Nov 26, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ibuprofen; oxycodone hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Forest Labs
COMBUNOX
ibuprofen; oxycodone hydrochloride
TABLET;ORAL021378-001Nov 26, 2004► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Healthtrust
Federal Trade Commission
Daiichi Sankyo
Medtronic
Accenture
Covington
US Department of Justice
Argus Health
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot